Explainable Reinforcement Learning for Credit Underwriting and Clinical Trial Funding Decisions

Authors

  • Thasil Mohamed Software Development and Scientist, SwissRE, India Author
  • Lekhya Sai Sake Data Analyst, Cymansys Solutions, California, USA Author
  • Shahul Hameed Syed Massod Technical Lead, Solartis Technology, India Author
  • Marcus Rodriguez Computer Scientist, PICSciE, New Jersy, United States Author

Keywords:

explainable reinforcement learning, credit underwriting, clinical trial funding

Abstract

In this study, explainable reinforcement learning (XRL) frameworks improve credit underwriting, clinical trial funding transparency, regulatory compliance, and risk-sensitive resource allocation. Policy optimization, value function approximation, and limited Markov decision algorithms provide actionable, interpretable loan approval and research funding recommendations from historical financial and clinical data. Post-hoc explanation, feature attribution, and attention-based approaches adjust domain-specific risk profiles, historical outcomes, and multi-criteria regulatory constraints to changing data distributions while maintaining interpretability. According to thorough experimental testing, XRL models balance forecast accuracy, risk reduction, compliance, and stakeholder choice reasons. To prepare transparent reinforcement learning for high-stakes judgments, the effort addresses ethical, scalability, and integration issues with financial and healthcare information systems.

Downloads

Download data is not yet available.

References

Sutton, R. S., & Barto, A. G. (1998). Reinforcement Learning: An Introduction (book). MIT Press.

Mnih, V., Kavukcuoglu, K., Silver, D., et al. (2015). “Human-level control through deep reinforcement learning.” Nature, 518:529–533.

Silver, D., Huang, A., Maddison, C. J., et al. (2016). “Mastering the game of Go with deep neural networks and tree search.” Nature, 529:484–489.

Silver, D., Schrittwieser, J., Simonyan, K., et al. (2017). “Mastering the game of Go without human knowledge.” Nature (AlphaGo Zero).

Rusu, A. A., Colmenarejo, S. G., Gulcehre, C., et al. (2015). “Policy Distillation.” arXiv:1511.06295 — method to extract/transfer policies (useful for interpretable / compressed policies).

Ribeiro, M. T., Singh, S., & Guestrin, C. (2016). “Why Should I Trust You?: Explaining the Predictions of Any Classifier” (LIME). Proceedings of ACM SIGKDD / arXiv (2016).

Lundberg, S. M., & Lee, S.-I. (2017). “A Unified Approach to Interpreting Model Predictions” (SHAP). arXiv:1705.07874 / NeurIPS workshop material.

Doshi-Velez, F., & Kim, B. (2017). “Towards a Rigorous Science of Interpretable Machine Learning.” (position paper / arXiv).

Lipton, Z. C. (2016). “The Mythos of Model Interpretability.” arXiv (position/critique paper on interpretability).

Hein, D., Udluft, S., & Runkler, T. A. (2017). “Interpretable Policies for Reinforcement Learning by Genetic Programming.” arXiv:1712.04170 (policy extraction / interpretable policy equations).

Villar, S. S., Bowden, J., & Wason, J. (2015). “Multi-armed bandit models for the optimal design of clinical trials: benefits and challenges.” Statistical Science 30(2):199–215. (Bandits ↔ clinical trial design).

Bhatt, D. L., Mehta, S. R., & other authors. (2016). “Adaptive designs for clinical trials.” NEJM review (on adaptive trials and practical/statistical considerations).

Hakoum, M. B., et al. (2017). “Characteristics of funding of clinical trials: cross-sectional analysis.” BMJ Open / PMC (study characterizing trial funding).

Thomas, L. C., Crook, J. N., & Edelman, D. B. (2002; 2nd ed. 2017). Credit Scoring and Its Applications. SIAM / standard reference for credit scoring methods and practice.

Baesens, B., Van Gestel, T., Viaene, S., Stepanova, M., Suykens, J., & Vanthienen, J. (2003). “Benchmarking state-of-the-art classification algorithms for credit scoring.” J. Operational Research Society, 54(6):627–635.

Lessmann, S., Baesens, B., Seow, H.-V., & Thomas, L. C. (2015). “Benchmarking state-of-the-art classification algorithms for credit scoring: an update.” EJOR / paper (update comparing many classifiers in credit scoring).

Hand, D. J. (2006). “Classifier Technology and the Illusion of Progress.” Statistical Science (important cautionary perspective on classifier improvements vs. real-world utility).

Caruana, R., Lou, Y., Gehrke, J., Koch, P., Sturm, M., & Elhadad, N. (2015). “Intelligible Models for HealthCare: Predicting Pneumonia Risk and Hospital 30-day Readmission.” KDD 2015 — interpretable, high-accuracy models for clinical settings.

Knox, W. B., & Stone, P. (2009). “Interactively Shaping Agents via Human Reinforcement: the TAMER framework.” K-CAP / ACM (human feedback for shaping RL agents — relevant to explainability / human-in-the-loop).

Thompson, W. R. (1933). “On the likelihood that one unknown probability exceeds another in view of the evidence of two samples.” Biometrika — (origin of Thompson Sampling; historical bandit method).

Downloads

Published

18-01-2018

How to Cite

[1]
T. Mohamed, L. S. Sake, S. H. S. Massod, and M. Rodriguez, “Explainable Reinforcement Learning for Credit Underwriting and Clinical Trial Funding Decisions”, J. Artif. Intell. Mach. Learn. Stud., vol. 2, pp. 1–32, Jan. 2018, Accessed: May 28, 2026. [Online]. Available: https://jaimls.org/index.php/publication/article/view/45